Hayes HM, Tarone RE, Cantor KP, Jessen CR, McCurnin DM, Richardson RC: Case-control study of canine malignant lymphoma: positive association with dog owner's use of 2,4-dichlorophenoxyacetic acid herbicides. J Natl Cancer Inst. 1991, 83: 1226-1231. 10.1093/jnci/83.17.1226.
Article
CAS
PubMed
Google Scholar
Fournel-Fleury C, Magnol JP, Bricaire P, Marchal T, Chabanne L, Delverdier A, Bryon PA, Felman P: Cytohistological and immunological classification of canine malignant lymphomas: comparison with human non-Hodgkin's lymphomas. J Comp Pathol. 1997, 117: 35-59. 10.1016/S0021-9975(97)80065-5.
Article
CAS
PubMed
Google Scholar
Hansen K, Khanna C: Spontaneous and genetically engineered animal models; use in preclinical cancer drug development. Eur J Cancer. 2004, 40: 858-880. 10.1016/j.ejca.2003.11.031.
Article
CAS
PubMed
Google Scholar
Greenlee PG, Filippa DA, Quimby FW, Patnaik AK, Calvano SE, Matus RE, Kimmel M, Hurvitz AI, Lieberman PH: Lymphomas in dogs. A morphologic, immunologic, and clinical study. Cancer. 1990, 66: 480-490. 10.1002/1097-0142(19900801)66:3<480::AID-CNCR2820660314>3.0.CO;2-X.
Article
CAS
PubMed
Google Scholar
Burnett RC, Vernau W, Modiano JF, Olver CS, Moore PF, Avery AC: Diagnosis of canine lymphoid neoplasia using clonal rearrangements of antigen receptor genes. Vet Pathol. 2003, 40: 32-41. 10.1354/vp.40-1-32.
Article
CAS
PubMed
Google Scholar
Hahn KA, Richardson RC, Hahn EA, Chrisman CL: Diagnostic and prognostic importance of chromosomal aberrations identified in 61 dogs with lymphosarcoma. Vet Pathol. 1994, 31: 528-540.
Article
CAS
PubMed
Google Scholar
Lana SE, Ogilvie GK, Hansen RA, Powers BE, Dernell WS, Withrow SJ: Identification of matrix metalloproteinases in canine neoplastic tissue. Am J Vet Res. 2000, 61: 111-114. 10.2460/ajvr.2000.61.111.
Article
CAS
PubMed
Google Scholar
Valli VE, Vernau W, de Lorimier LP, Graham PS, Moore PF: Canine indolent nodular lymphoma. Vet Pathol. 2006, 43: 241-256. 10.1354/vp.43-3-241.
Article
CAS
PubMed
Google Scholar
Johnston PB, Bondly C, Micallef IN: Ibritumomab tiuxetan for non-Hodgkin's lymphoma. Expert Rev Anticancer Ther. 2006, 6: 861-869. 10.1586/14737140.6.6.861.
Article
CAS
PubMed
Google Scholar
Fosmire SP, Thomas R, Jubala CM, Wojcieszyn JW, Valli VE, Getzy DM, Smith TL, Gardner LA, Ritt MG, Bell JS, Freeman KP, Greenfield BE, Lana SE, Kisseberth WC, Helfand SC, Cutter GR, Breen M, Modiano JF: Inactivation of the p16 cyclin-dependent kinase inhibitor in high-grade canine non-Hodgkin's T-cell lymphoma. Vet Pathol. 2007, 44: 467-478. 10.1354/vp.44-4-467.
Article
CAS
PubMed
Google Scholar
Modiano JF, Breen M, Valli VE, Wojcieszyn JW, Cutter GR: Predictive value of p16 or Rb inactivation in a model of naturally occurring canine non-Hodgkin's lymphoma. Leukemia. 2007, 21: 184-187. 10.1038/sj.leu.2404392.
Article
CAS
PubMed
Google Scholar
Sokolowska J, Cywinska A, Malicka E: p53 expression in canine lymphoma. J Vet Med A Physiol Pathol Clin Med. 2005, 52: 172-175.
Article
CAS
PubMed
Google Scholar
Yuan BZ, Miller MJ, Keck CL, Zimonjic DB, Thorgeirsson SS, Popescu NC: Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. Cancer Res. 1998, 58: 2196-2199.
CAS
PubMed
Google Scholar
Xue W, Krasnitz A, Lucito R, Sordella R, Vanaelst L, Cordon-Cardo C, Singer S, Kuehnel F, Wigler M, Powers S, Zender L, Lowe SW: DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma. Genes Dev. 2008, 22: 1439-1444. 10.1101/gad.1672608.
Article
PubMed Central
CAS
PubMed
Google Scholar
Wong CM, Lee JM, Ching YP, Jin DY, Ng IO: Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma. Cancer Res. 2003, 63: 7646-7651.
CAS
PubMed
Google Scholar
Sahai E, Marshall CJ: RHO-GTPases and cancer. Nat Rev Cancer. 2002, 2: 133-142. 10.1038/nrc725.
Article
PubMed
Google Scholar
Ullmannova-Benson V, Guan M, Zhou X, Tripathi V, Yang XY, Zimonjic DB, Popescu NC: DLC1 tumor suppressor gene inhibits migration and invasion of multiple myeloma cells through RhoA GTPase pathway. Leukemia. 2009, 23: 383-390. 10.1038/leu.2008.285.
Article
PubMed Central
CAS
PubMed
Google Scholar
Yuan BZ, Jefferson AM, Baldwin KT, Thorgeirsson SS, Popescu NC, Reynolds SH: DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas. Oncogene. 2004, 23: 1405-1411. 10.1038/sj.onc.1207291.
Article
CAS
PubMed
Google Scholar
Goodison S, Yuan J, Sloan D, Kim R, Li C, Popescu NC, Urquidi V: The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells. Cancer Res. 2005, 65: 6042-6053. 10.1158/0008-5472.CAN-04-3043.
Article
PubMed Central
CAS
PubMed
Google Scholar
Wu PP, Jin YL, Shang YF, Jin Z, Wu P, Huang PL: Restoration of DLC1 gene inhibits proliferation and migration of human colon cancer HT29 cells. Ann Clin Lab Sci. 2009, 39: 263-269.
CAS
PubMed
Google Scholar
Liao YC, Si L, Vere White RW, Lo SH: The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1. J Cell Biol. 2007, 176: 43-49. 10.1083/jcb.200608015.
Article
PubMed Central
CAS
PubMed
Google Scholar
Wong CM, Yam JW, Ching YP, Yau TO, Leung TH, Jin DY, Ng IO: Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma. Cancer Res. 2005, 65: 8861-8868. 10.1158/0008-5472.CAN-05-1318.
Article
CAS
PubMed
Google Scholar
Scholz RP, Regner J, Theil A, Erlmann P, Holeiter G, Jahne R, Schmid S, Hausser A, Olayioye MA: DLC1 interacts with 14-3-3 proteins to inhibit RhoGAP activity and block nucleocytoplasmic shuttling. J Cell Sci. 2009, 122: 92-102. 10.1242/jcs.036251.
Article
CAS
PubMed
Google Scholar
Chan LK, Ko FC, Ng IO, Yam JW: Deleted in liver cancer 1 (DLC1) utilizes a novel binding site for Tensin2 PTB domain interaction and is required for tumor-suppressive function. PLoS ONE. 2009, 4: e5572-10.1371/journal.pone.0005572.
Article
PubMed Central
PubMed
Google Scholar
Yam JW, Ko FC, Chan CY, Jin DY, Ng IO: Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression. Cancer Res. 2006, 66: 8367-8372. 10.1158/0008-5472.CAN-05-2850.
Article
CAS
PubMed
Google Scholar
Yang XY, Guan M, Vigil D, Der CJ, Lowy DR, Popescu NC: p120Ras-GAP binds the DLC1 Rho-GAP tumor suppressor protein and inhibits its RhoA GTPase and growth-suppressing activities. Oncogene. 2009, 28: 1401-1409. 10.1038/onc.2008.498.
Article
PubMed Central
CAS
PubMed
Google Scholar
Shi H, Guo J, Duff DJ, Rahmatpanah F, Chitima-Matsiga R, Al-Kuhlani M, Taylor KH, Sjahputera O, Andreski M, Wooldridge JE, Caldwell CW: Discovery of novel epigenetic markers in non-Hodgkin's lymphoma. Carcinogenesis. 2006, 28: 60-70. 10.1093/carcin/bgl092.
Article
PubMed
Google Scholar
Pelham JT, Irwin PJ, Kay PH: Genomic hypomethylation in neoplastic cells from dogs with malignant lymphoproliferative disorders. Res Vet Sci. 2003, 74: 101-104. 10.1016/S0034-5288(02)00179-0.
Article
CAS
PubMed
Google Scholar
Bryan JN, Taylor KH, Henry CJ, Selting KA, Rahmatpanah F, Lewis MR, Caldwell CW: DNA methylation in cancer: techniques and preliminary evidence of hypermethylation in canine lymphoma. Cancer Therapy. 2008, 6: 137-148.
CAS
Google Scholar
Herman JG, Baylin SB: Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med. 2003, 349: 2042-2054. 10.1056/NEJMra023075.
Article
CAS
PubMed
Google Scholar
Pang JC, Chang Q, Chung YF, Teo JG, Poon WS, Zhou LF, Kong X, Ng HK: Epigenetic inactivation of DLC-1 in supratentorial primitive neuroectodermal tumor. Hum Pathol. 2005, 36: 36-43. 10.1016/j.humpath.2004.09.021.
Article
CAS
PubMed
Google Scholar
Kim TY, Jong HS, Song SH, Dimtchev A, Jeong SJ, Lee JW, Kim TY, Kim NK, Jung M, Bang YJ: Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells. Oncogene. 2003, 22: 3943-3951. 10.1038/sj.onc.1206573.
Article
CAS
PubMed
Google Scholar
Yuan BZ, Durkin ME, Popescu NC: Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers. Cancer Genet Cytogenet. 2003, 140: 113-117. 10.1016/S0165-4608(02)00674-X.
Article
CAS
PubMed
Google Scholar
Ullmannova V, Popescu NC: Expression profile of the tumor suppressor genes DLC-1 and DLC-2 in solid tumors. Int J Oncol. 2006, 29: 1127-1132.
CAS
PubMed
Google Scholar
Seng TJ, Low JS, Li H, Cui Y, Goh HK, Wong ML, Srivastava G, Sidransky D, Califano J, Steenbergen RD, Rha SY, Tan J, Hsieh WS, Ambinder RF, Lin X, Chan AT, Tao Q: The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation. Oncogene. 2007, 26: 934-944. 10.1038/sj.onc.1209839.
Article
CAS
PubMed
Google Scholar
Siegfried Z, Eden S, Mendelsohn M, Feng X, Tsuberi BZ, Cedar H: DNA methylation represses transcription in vivo. Nat Genet. 1999, 22: 203-206. 10.1038/9727.
Article
CAS
PubMed
Google Scholar
Guan M, Zhou X, Soulitzis N, Spandidos DA, Popescu NC: Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications. Clin Cancer Res. 2006, 12: 1412-1419. 10.1158/1078-0432.CCR-05-1906.
Article
CAS
PubMed
Google Scholar
Butcher DT, Mancini-DiNardo DN, Archer TK, Rodenhiser DI: DNA binding sites for putative methylation boundaries in the unmethylated region of the BRCA1 promoter. Int J Cancer. 2004, 111: 669-678. 10.1002/ijc.20324.
Article
CAS
PubMed
Google Scholar
Devereux TR, Horikawa I, Anna CH, Annab LA, Afshari CA, Barrett JC: DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene. Cancer Res. 1999, 59: 6087-6090.
CAS
PubMed
Google Scholar
Dessain SK, Yu H, Reddel RR, Beijersbergen RL, Weinberg RA: Methylation of the human telomerase gene CpG island. Cancer Res. 2000, 60: 537-541.
CAS
PubMed
Google Scholar
Nomoto K, Maekawa M, Sugano K, Ushiama M, Fukayama N, Fujita S, Kakizoe T: Methylation status and expression of human telomerase reverse transcriptase mRNA in relation to hypermethylation of the p16 gene in colorectal cancers as analyzed by bisulfite PCR-SSCP. Jpn J Clin Oncol. 2002, 32: 3-8. 10.1093/jjco/hyf001.
Article
PubMed
Google Scholar
Zinn RL, Pruitt K, Eguchi S, Baylin SB, Herman JG: hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site. Cancer Res. 2007, 67: 194-201. 10.1158/0008-5472.CAN-06-3396.
Article
CAS
PubMed
Google Scholar
Taylor KH, Pena-Hernandez KE, Davis JW, Arthur GL, Duff DJ, Shi H, Rahmatpanah FB, Sjahputera O, Caldwell CW: Large-scale CpG methylation analysis identifies novel candidate genes and reveals methylation hotspots in acute lymphoblastic leukemia. Cancer Res. 2007, 67: 2617-2625. 10.1158/0008-5472.CAN-06-3993.
Article
CAS
PubMed
Google Scholar
Fraga MF, Agrelo R, Esteller M: Cross-talk between aging and cancer: the epigenetic language. Ann N Y Acad Sci. 2007, 1100: 60-74. 10.1196/annals.1395.005.
Article
CAS
PubMed
Google Scholar
Guo J, Burger M, Nimmrich I, Maier S, Becker E, Genc B, Duff D, Rahmatpanah F, Chitma-Matsiga R, Shi H, Berlin K, Huang TH, Caldwell CW: Differential DNA methylation of gene promoters in small B-cell lymphomas. Am J Clin Pathol. 2005, 124: 430-439. 10.1309/LCGNV77J464LNFD6.
Article
CAS
PubMed
Google Scholar
Rahmatpanah FB, Carstens S, Guo J, Sjahputera O, Taylor KH, Duff D, Shi H, Davis JW, Hooshmand SI, Chitma-Matsiga R, Caldwell CW: Differential DNA methylation patterns of small B-cell lymphoma subclasses with different clinical behavior. Leukemia. 2006, 20: 1855-1862. 10.1038/sj.leu.2404345.
Article
CAS
PubMed
Google Scholar
Taylor KH, Kramer RS, Davis JW, Guo J, Duff DJ, Xu D, Caldwell CW, Shi H: Ultradeep bisulfite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing. Cancer Res. 2007, 67: 8511-8518. 10.1158/0008-5472.CAN-07-1016.
Article
CAS
PubMed
Google Scholar
Culmsee K, Simon D, Mischke R, Nolte I: Possibilities of flow cytometric analysis for immunophenotypic characterization of canine lymphoma. J Vet Med A Physiol Pathol Clin Med. 2001, 48: 199-206.
Article
CAS
PubMed
Google Scholar
Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG: Clustal W and Clustal X version 2.0. Bioinformatics. 2007, 23: 2947-2948. 10.1093/bioinformatics/btm404.
Article
CAS
PubMed
Google Scholar
Zdobnov EM, Apweiler R: InterProScan--an integration platform for the signature-recognition methods in InterPro. Bioinformatics. 2001, 17: 847-848. 10.1093/bioinformatics/17.9.847.
Article
CAS
PubMed
Google Scholar
McCaw DL, Chan AS, Stegner AL, Mooney B, Bryan JN, Turnquist SE, Henry CJ, Alexander H, Alexander S: Proteomics of canine lymphoma identifies potential cancer-specific protein markers. Clin Cancer Res. 2007, 13: 2496-2503. 10.1158/1078-0432.CCR-06-2699.
Article
CAS
PubMed
Google Scholar
Li LC, Dahiya R: MethPrimer: designing primers for methylation PCRs. Bioinformatics. 2002, 18: 1427-1431. 10.1093/bioinformatics/18.11.1427.
Article
CAS
PubMed
Google Scholar